Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
$ABT (Abbott Laboratories) delivered a mixed first-quarter report that nonetheless fueled a noticeable rally. Shares closed at $129.70, up 2.76% on the day, reflecting a strong response from investors despite headline revenue missing by $60 million. The market instead chose to focus on a beat on non-GAAP EPS at $1.09 (vs. $1.07 expected) and strength in Abbott’s core medical device and nutrition segments. This was seen as validation of management’s strategic diversification and operational execution, particularly as Covid-related sales decline. Intraday, $ABT showed impressive resilience, bouncing sharply off its 50-day moving average, even as broader indices like the Nasdaq fell over 2%. That reaction speaks to the stock’s relative strength and renewed investor confidence. Abbott’s RSI at 52.39 supports the view of a balanced, albeit slightly bullish setup, with the stock trading just above its 20-day MA. It remains in a technical sideways trend, but a clear move above $130 could trigger a shift toward the 52-week high at $141.23.
On the other hand, $ALV (Autoliv Inc.) posted a stellar earnings beat that sent the stock soaring 5.56% to close at $86.81. The company topped both top and bottom line estimates and even went a step further by updating its full-year guidance, reflecting strong demand across the automotive safety sector. While $ALV is still technically in a downtrend and trading below its 50-day MA, this post-earnings move could be an early sign of a trend reversal. Volume surged to 2.01 million, nearly double its average, suggesting institutional participation. Although RSI remains below the midpoint at 49.43, the positive reaction indicates traders are reassessing the stock’s valuation, particularly given its attractive 10.8 P/E ratio in a sector that's expected to rebound with global vehicle production.
Looking at the broader picture, $ALLY, $AXP, and $BX are all due to report Thursday night or early Friday. $ALLY has been drifting sideways near $32.18, with weak momentum indicators and below-average volume, suggesting a tepid setup heading into earnings. $AXP, currently down nearly 2% on the day at $252.92, remains in a short-term downtrend and is trading below all major moving averages. Investor sentiment appears cautious, possibly bracing for weaker consumer spending data. Lastly, $BX has been hit harder, dropping 3.09% today to close at $129.38. Its downtrend remains intact, and the current RSI of 40.61 reflects oversold territory, which might trigger a short-term technical bounce—if earnings don’t disappoint.
All in all, Thursday’s late-night wrap offers mixed signals: some companies like $ABT and $ALV are being rewarded for operational strength and earnings outperformance, while others await judgment in the next session. Friday’s pre-market action will hinge heavily on how investors digest these upcoming reports, particularly in the context of broader market weakness and rising volatility.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.